7 days ago
ABVX
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 7%
#336 out of 5057 analysts
Average Return
+31.21%
Win Rate
60%37 out of 62
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cymabay Therapeutics IncCBAY | +262.63% | $8.91 | $32.31 | 2023-03-08 - 2024-03-08 | Strong Buy |
Prometheus Biosciences IncRXDX | +233.20% | $60.00 | $199.92 | 2022-10-02 - 2023-06-15 | Strong Buy |
Cymabay Therapeutics IncCBAY | +212.31% | $10.40 | $32.48 | 2023-05-14 - 2024-03-21 | Strong Buy |
Cymabay Therapeutics IncCBAY | +199.91% | $10.83 | $32.48 | 2023-04-30 - 2024-03-21 | Strong Buy |
Cymabay Therapeutics IncCBAY | +193.67% | $11.06 | $32.48 | 2023-07-04 - 2024-03-21 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
14 days ago
CLYM
a month ago
MAZE
4 months ago
TBPH
10 months ago
OTLK
a year ago
VRDN
a year ago
VRDN
a year ago
PTGX
a year ago
SYRE
2 years ago
CBAY
2 years ago
CBAY
2 years ago
CBAY
3 years ago
KROS
3 years ago
RXDX
3 years ago
RXDX
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $15.00 | +124.22% | Maintains | 19 hours ago |
Apogee Therapeutics IncAPGE | 2 | Strong Buy | $115.00 | +113.08% | Reiterates | 5 days ago |
Jade Biosciences IncJBIO | 4 | Strong Buy | $28.00 | +208.03% | Initiates Coverage On | 5 days ago |
Abivax SaABVX | 3 | Strong Buy | $120.00 | +25.48% | Maintains | 7 days ago |
Climb Bio IncCLYM | 2 | Strong Buy | $8.00 | +300.00% | Maintains | 14 days ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Hold | $85.00 | +697.37% | Downgrades | 15 days ago |
Oruka Therapeutics IncORKA | 2 | Strong Buy | $56.00 | +119.56% | Reiterates | 15 days ago |
Avalo Therapeutics IncAVTX | 2 | Strong Buy | $40.00 | +192.61% | Reiterates | 15 days ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $100.00 | +74.22% | Reiterates | 25 days ago |
Rezolute IncRZLT | 3 | Strong Buy | $17.00 | +110.66% | Reiterates | a month ago |
Spyre Therapeutics IncSYRE | 3 | Strong Buy | $70.00 | +270.08% | Reiterates | a month ago |
Maze Therapeutics IncMAZE | 3 | Strong Buy | $37.00 | +29.51% | Maintains | a month ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $32.00 | +308.68% | Reiterates | a month ago |
Theravance Biopharma IncTBPH | 2 | Strong Buy | $25.00 | +79.60% | Maintains | 4 months ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $42.00 | +342.34% | Initiates Coverage On | 10 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | +587.02% | Maintains | 10 months ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | +318.85% | Upgrades | a year ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | +2,073.91% | Initiates Coverage On | a year ago |
Viridian Therapeutics IncVRDN | 3 | Strong Buy | $61.00 | N/A | Maintains | a year ago |
Liquidia CorpLQDA | 3 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $51.00 | N/A | Maintains | a year ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $4.00 | N/A | Assumes | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 2 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 2 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 3 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 3 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.